QuantiFERON Change During Anti-tuberculosis Medication

This study has been completed.
Sponsor:
Information provided by:
Armed Forces Capital Hospital, Republic of Korea
ClinicalTrials.gov Identifier:
NCT01038830
First received: December 23, 2009
Last updated: June 11, 2010
Last verified: December 2009
  Purpose

The aim of this study is to evaluate the change of QuantiFERON-TB gold in tube assay (QFT) during the treatment of active tuberculosis.


Condition
Tuberculosis
Interferon-gamma Release Assay

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: The Change in Level of Interferon-gamma Assay in Active Tuberculosis Patients During Treatment

Resource links provided by NLM:


Further study details as provided by Armed Forces Capital Hospital, Republic of Korea:

Estimated Enrollment: 50
Study Start Date: May 2008
Study Completion Date: May 2010
Primary Completion Date: April 2010 (Final data collection date for primary outcome measure)
Detailed Description:

Patients with active pulmonary tuberculosis are enrolled and, QFTs are performed for each subjects before treatment and 1, 3, 6 months after treatment. Investigators check the level of interferon-gamma, and reversion and conversion of this test.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Young healthy subjects in Korean military

Criteria

Inclusion Criteria:

  • All subjects with active tuberculosis

Exclusion Criteria:

  • Subjects who cannot complete study
  • Subjects who have taken anti-tuberculosis medication for more than a month before visit of our hospital
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01038830

Locations
Korea, Republic of
Armed Forces Capital Hospital
Seongnam, Gyeonggi-do, Korea, Republic of, 463-040
Sponsors and Collaborators
Armed Forces Capital Hospital, Republic of Korea
  More Information

No publications provided

Responsible Party: Sei Won Lee/Division chief of pulmonology, Armed Forces Capital Hospital
ClinicalTrials.gov Identifier: NCT01038830     History of Changes
Other Study ID Numbers: QFTchange
Study First Received: December 23, 2009
Last Updated: June 11, 2010
Health Authority: Korea: Food and Drug Administration

Additional relevant MeSH terms:
Tuberculosis
Mycobacterium Infections
Actinomycetales Infections
Gram-Positive Bacterial Infections
Bacterial Infections

ClinicalTrials.gov processed this record on April 17, 2014